Literature DB >> 10482994

Cytosine demethylation of the proteinase-3/myeloblastin primary granule protease gene during phagocyte development.

M Lübbert1, A Tobler, M Daskalakis.   

Abstract

Proteinase-3/Myeloblastin (Mbn) is a neutral serine protease and a major constituent of the primary granules of myeloid cells. It can degrade extracellular matrix proteins and has been discussed as a key factor for the initiation of terminal differentiation in promyelocytic cells. Regulation of Mbn closely parallels that of another major primary granule protein, myeloperoxidase (MPO). We examined the expression and DNA methylation of Mbn in a model of in vitro differentiation of CD34+ enriched peripheral blood progenitor cells (PBPCs), and in various other myeloid and non-myeloid tissues. Mbn mRNA was undetectable in uncultured PBPCs but was upregulated during their in vitro differentiation. Its expression was enhanced in the presence of G-CSF. Mbn expression was also detected in several myeloid cell lines but not in mature granulocytes, monocytes and macrophages. Partial demethylation at a CpG site within Mbn intron 1 (analyzed by restriction with SmaI) was observed during continued in vitro differentiation of PBPCs. This site was fully demethylated in mature granulocytes, monocytes and macrophages. Variable methylation of this site and a second SmaI site located upstream of the putative Mbn promoter region was present in other myeloid and non-myeloid tissues examined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482994     DOI: 10.1038/sj.leu.2401486

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  4 in total

Review 1.  NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.

Authors:  Edwin P Alyea; Daniel J DeAngelo; Jeffrey Moldrem; John M Pagel; Donna Przepiorka; Michel Sadelin; James W Young; Sergio Giralt; Michael Bishop; Stan Riddell
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-24       Impact factor: 5.742

2.  Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia.

Authors:  Sally L Rogers; Yun Zhao; Xiaoyan Jiang; Connie J Eaves; Dixie L Mager; Arefeh Rouhi
Journal:  Mol Cancer       Date:  2010-02-22       Impact factor: 27.401

3.  Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis.

Authors:  Dominic J Ciavatta; Jiajin Yang; Gloria A Preston; Anshul K Badhwar; Hong Xiao; Peter Hewins; Carla M Nester; William F Pendergraft; Terry R Magnuson; J Charles Jennette; Ronald J Falk
Journal:  J Clin Invest       Date:  2010-08-16       Impact factor: 14.808

4.  Delineating the effect of demethylating agent 5-aza-2'-deoxycytidine on human Caco-2 colonic carcinoma cells.

Authors:  Xiumei Li; Bingzhao Qin; B O Liu
Journal:  Oncol Lett       Date:  2016-05-09       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.